IRIS Institutional Research Information System - OPENBS Open Archive UniBS

Abate, Andrea
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 2.538
AS - Asia 1.189
EU - Europa 1.039
SA - Sud America 181
Continente sconosciuto - Info sul continente non disponibili 63
AF - Africa 20
OC - Oceania 11
Totale 5.041
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 2.477
SG - Singapore 446
IT - Italia 308
CN - Cina 303
BR - Brasile 143
PL - Polonia 140
DE - Germania 133
FI - Finlandia 124
VN - Vietnam 90
HK - Hong Kong 85
BD - Bangladesh 71
GB - Regno Unito 59
IN - India 55
FR - Francia 51
CA - Canada 40
RU - Federazione Russa 40
SE - Svezia 36
UA - Ucraina 33
TR - Turchia 30
JP - Giappone 25
NL - Olanda 19
ID - Indonesia 18
IE - Irlanda 17
MX - Messico 13
IQ - Iraq 12
AR - Argentina 11
BE - Belgio 11
CH - Svizzera 11
ES - Italia 10
AU - Australia 9
CL - Cile 9
CZ - Repubblica Ceca 8
PK - Pakistan 8
ZA - Sudafrica 8
DK - Danimarca 7
EC - Ecuador 7
VE - Venezuela 7
LT - Lituania 6
AT - Austria 5
KR - Corea 5
PT - Portogallo 5
TH - Thailandia 5
EG - Egitto 4
JO - Giordania 4
SA - Arabia Saudita 4
AE - Emirati Arabi Uniti 3
CR - Costa Rica 3
EE - Estonia 3
HU - Ungheria 3
LB - Libano 3
RO - Romania 3
DZ - Algeria 2
GT - Guatemala 2
IL - Israele 2
KZ - Kazakistan 2
MA - Marocco 2
MD - Moldavia 2
NP - Nepal 2
NZ - Nuova Zelanda 2
OM - Oman 2
PH - Filippine 2
PS - Palestinian Territory 2
RS - Serbia 2
TN - Tunisia 2
TW - Taiwan 2
UZ - Uzbekistan 2
AL - Albania 1
AM - Armenia 1
AO - Angola 1
AZ - Azerbaigian 1
BB - Barbados 1
BH - Bahrain 1
BS - Bahamas 1
CO - Colombia 1
ET - Etiopia 1
GY - Guiana 1
JM - Giamaica 1
LK - Sri Lanka 1
LV - Lettonia 1
MY - Malesia 1
NO - Norvegia 1
PY - Paraguay 1
QA - Qatar 1
UY - Uruguay 1
XK - ???statistics.table.value.countryCode.XK??? 1
Totale 4.979
Salva come PNG Salva come JPEG
Città #
Singapore 236
Ashburn 221
Chicago 175
San Jose 172
Warsaw 138
Dallas 130
Los Angeles 118
New York 97
Helsinki 85
Hong Kong 83
Fairfield 81
Beijing 77
Brescia 76
Salt Lake City 76
Council Bluffs 64
Secaucus 64
The Dalles 60
Chandler 59
Seattle 48
Munich 45
Tampa 38
West Jordan 38
Woodbridge 37
Columbus 35
Elk Grove Village 35
Wilmington 33
Buffalo 32
Santa Clara 31
Des Moines 29
Houston 29
Lauterbourg 28
Ho Chi Minh City 27
Shanghai 26
Turku 26
Milan 24
Princeton 24
Cambridge 22
Istanbul 22
Jacksonville 22
Sterling 22
Tokyo 21
Rome 20
Lancaster 19
Moscow 18
Dublin 17
Hanoi 17
Jakarta 15
Pune 14
Brooklyn 13
Phoenix 13
San Francisco 13
Bergamo 12
Boardman 12
Montreal 12
Brussels 11
Dalmine 11
Orem 11
Redondo Beach 11
São Paulo 11
Amsterdam 10
Ann Arbor 10
Dong Ket 10
Frankfurt am Main 10
Chennai 9
Lappeenranta 9
Romola 9
Atlanta 8
Brno 8
Denver 8
Miami 8
Naples 8
New Delhi 8
Banstead 7
Detroit 7
Dulles 7
Kansas City 7
Kyiv 7
Las Vegas 7
London 7
Philadelphia 7
Poplar 7
Stockholm 7
Calcinate 6
Da Nang 6
Dearborn 6
Düsseldorf 6
Haiphong 6
Indianapolis 6
Johannesburg 6
Mumbai 6
Nuremberg 6
Pescara 6
Pittsburgh 6
Rio de Janeiro 6
San Diego 6
Boston 5
Charlotte 5
Hangzhou 5
Toronto 5
Vancouver 5
Totale 3.244
Salva come PNG Salva come JPEG
Nome #
Cytotoxic Effect of Progesterone, Tamoxifen and Their Combination in Experimental Cell Models of Human Adrenocortical Cancer 794
Adrenocortical carcinoma xenograft in zebrafish embryos as model to study the in vivo cytotoxicity of abiraterone acetate 318
Are we failing in treatment of adrenocortical carcinoma? Lights and shadows of molecular signatures 258
In vitro cytotoxicity of cabazitaxel in adrenocortical carcinoma cell lines and human adrenocortical carcinoma primary cell cultures☆ 252
AdrenoCortical Carcinoma: in search of new pharmacological strategies 242
Cytotoxic Effect of Trabectedin In Human Adrenocortical Carcinoma Cell Lines and Primary Cells 230
Molecular Drivers of Potential Immunotherapy Failure in Adrenocortical Carcinoma. 203
A Comprehensive Investigation of Steroidogenic Signaling in Classical and New Experimental Cell Models of Adrenocortical Carcinoma 167
Cisplatin Cytotoxicity in Human Testicular Germ Cell Tumor Cell Lines Is Enhanced by the CDK4/6 Inhibitor Palbociclib 163
Ribociclib Cytotoxicity Alone Or Combined With Progesterone And/Or Mitotane In In Vitro Adrenocortical Carcinoma Cells 147
Advances in adrenocortical carcinoma pharmacotherapy: what is the current state of the art? 128
Preclinical Evidence of Progesterone as a New Pharmacological Strategy in Human Adrenocortical Carcinoma Cell Lines 126
Estrogen-Like Effect of Mitotane Explained by Its Agonist Activity on Estrogen Receptor-α 121
Novel cellular systems unveil mucosal melanoma initiating cells and a role for PI3K/Akt/mTOR pathway in mucosal melanoma fitness 120
Supportive therapies in patients with advanced adrenocortical carcinoma submitted to standard EDP-M regimen 119
Outcome of brain metastases from adrenocortical carcinoma: a pooled analysis 117
Cytotoxic effects of targeted agent alone or with chemotherapy in the treatment of adenoid cystic carcinoma: a preclinical study 114
Trabectedin impairs invasiveness and metastasis in adrenocortical carcinoma preclinical models 113
Feasibility and Activity of Megestrol Acetate in Addition to Etoposide, Doxorubicin, Cisplatin, and Mitotane as First-Line Therapy in Patients with Metastatic/Unresectable Adrenocortical Carcinoma with Low Performance Status 113
The CDK Inhibitor Dinaciclib Improves Cisplatin Response in Nonseminomatous Testicular Cancer: A Preclinical Study 113
An update on adrenocortical cell lines of human origin 105
Correction to: A Comprehensive Investigation of Steroidogenic Signaling in Classical and New Experimental Cell Models of Adrenocortical Carcinoma (Cells, (2022), 11, 9, (1439), 10.3390/cells11091439) 104
Phase II study of cabazitaxel as second-third line treatment in patients with metastatic adrenocortical carcinoma 103
A Database Tool Integrating Genomic and Pharmacologic Data from Adrenocortical Carcinoma (ACC) Cell Lines, PDX, and Patient Samples 87
Dlk1 is a novel adrenocortical stem/progenitor cell marker that predicts malignancy in adrenocortical carcinoma 84
RETROSPECTIVE ANALYSIS OF THE PATIENT-REPORTED ADVERSE DRUG REACTIONS IN AN ITALIAN ALLERGY UNIT: ALLERG-RAF STUDY 80
Cancer cell xenografts in zebrafish embryos as an experimental tool in drug screening for adrenocortical carcinoma 79
Human and Murine Cell Lines for Adrenocortical Carcinoma and Pheochromocytoma 74
FGF/FGFR inhibitors downmodulates c-Myc oncoprotein and hampers the growth of adrenocortical carcinoma 68
Chemo-immunotherapy with cisplatin and nivolumab as second-line approach in metastatic adrenocortical carcinoma 66
null 51
Prognostic role of pretreatment [18F]FDG PET/CT in patients affected by adrenocortical carcinoma and treated with chemotherapy 41
Correlation Between iXip and Final Pathology in Patients Affected by Prostate Cancer Undergoing Radical Prostatectomy: A Multicenter Prospective Trial (PROXIMA—PROstate iXip Index Multicenter Analysis) 35
(Non)canonical Wnt signaling, cytoarchitecture and stemness: new insights from primary nonmetastatic, primary metastatic, regional and distant metastatic models of adrenocortical carcinoma 34
Preclinical evaluation of progesterone combined with EDP-M scheme in 2D and 3D models of adrenocortical carcinoma 24
Pharmacological WEE1 inhibition as a strategy to overcome cisplatin resistance in non-seminoma testicular cancer: insights from preclinical models 24
Primary Adrenal Malignancies 16
Updating ACC preclinical models: characterization of two new patient-derived cell lines 8
Totale 5.041
Salva come PNG Salva come JPEG
Categoria #
all - tutte 20.540
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 20.540
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022148 0 9 4 19 6 13 11 4 4 31 17 30
2022/2023173 27 10 13 13 17 32 4 19 25 1 4 8
2023/2024393 14 12 28 26 24 72 11 48 46 53 16 43
2024/20251.475 47 25 19 156 66 61 47 41 141 56 283 533
2025/20262.144 145 248 194 201 184 152 295 114 151 208 149 103
2026/2027150 93 57 0 0 0 0 0 0 0 0 0 0
Totale 5.041